Search Results - "Capocci, Luca"
-
1
Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
Published in Scientific reports (24-01-2017)“…Blood-brain barrier (BBB) breakdown, due to the concomitant disruption of the tight junctions (TJs), normally required for the maintenance of BBB function, and…”
Get full text
Journal Article -
2
Treatment with the Glycosphingolipid Modulator THI Rescues Myelin Integrity in the Striatum of R6/2 HD Mice
Published in International journal of molecular sciences (01-03-2023)“…Huntington's disease is one of the most common dominantly inherited neurodegenerative disorders caused by an expansion of a polyglutamine (polyQ) stretch in…”
Get full text
Journal Article -
3
Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells
Published in International journal of molecular sciences (01-09-2022)“…Gliomas are the most common primary malignant brain tumors. Glioblastoma, IDH-wildtype (GBM, CNS WHO grade 4) is the most aggressive form of glioma and is…”
Get full text
Journal Article -
4
Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity
Published in Nature communications (05-07-2023)“…Huntington’s disease (HD) is a neurodegenerative disorder caused by CAG-repeat expansions in the huntingtin ( HTT ) gene. The resulting mutant HTT (mHTT)…”
Get full text
Journal Article -
5
Differential Expression of Sphingolipid Metabolizing Enzymes in Spontaneously Hypertensive Rats: A Possible Substrate for Susceptibility to Brain and Kidney Damage
Published in International journal of molecular sciences (06-04-2021)“…Alterations in the metabolism of sphingolipids, a class of biologically active molecules in cell membranes with direct effect on vascular homeostasis, are…”
Get full text
Journal Article -
6
Morus alba extract modulates blood pressure homeostasis through eNOS signaling
Published in Molecular nutrition & food research (01-10-2016)“…Scope Morus alba is a promising phytomedicine cultivated in oriental countries that is extensively used to prevent and treat various cardiovascular problems…”
Get full text
Journal Article -
7
Blood-Brain Barrier Integrity Is Perturbed in a Mecp2 -Null Mouse Model of Rett Syndrome
Published in Biomolecules (Basel, Switzerland) (28-03-2023)“…Rett syndrome (RTT, online MIM 312750) is a devastating neurodevelopmental disorder characterized by motor and cognitive disabilities. It is mainly caused by…”
Get full text
Journal Article -
8
Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington's Disease Pre-clinical Model
Published in Frontiers in molecular neuroscience (24-04-2019)“…Although several agents have been identified to provide therapeutic benefits in Huntington disease (HD), the number of conventionally used treatments remains…”
Get full text
Journal Article -
9
Vasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension?
Published in Frontiers in pharmacology (01-05-2017)“…The of tryptophan metabolism is activated by pro-inflammatory cytokines. L-kynurenine, an upstream metabolite of the pathway, acts as a putative…”
Get full text
Journal Article -
10
Brain Region and Cell Compartment Dependent Regulation of Electron Transport System Components in Huntington’s Disease Model Mice
Published in Brain sciences (24-09-2021)“…Huntington’s disease (HD) is a rare hereditary neurodegenerative disorder characterized by multiple metabolic dysfunctions including defects in mitochondrial…”
Get full text
Journal Article -
11
Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction
Published in Journal of the American Heart Association (01-03-2017)“…Background Endothelial dysfunction contributes significantly to the development of vascular diseases. However, a therapy able to reduce this derangement still…”
Get full text
Journal Article -
12
I08 Passive immunization, with the anti-huntingtin aggregate antibody EM48, is beneficial in R6/2 mouse model
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…BackgroundA critical step in the molecular events leading to mutant huntingtin (mHtt) toxicity, in Huntington’s disease (HD), is the generation of N-terminal…”
Get full text
Journal Article -
13
I18 Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase (SGPL1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of Huntington’s disease
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…BackgroundOver the past few years our research has shown that alterations in sphingolipid metabolism represent a critical determinant in Huntington’s disease…”
Get full text
Journal Article -
14
Abnormal expression of sphingolipid-metabolizing enzymes in the heart of spontaneously hypertensive rat models
Published in Biochimica et biophysica acta. Molecular and cell biology of lipids (01-01-2024)“…Sphingolipids exert important roles within the cardiovascular system and related diseases. Perturbed sphingolipid metabolism was previously reported in…”
Get full text
Journal Article -
15
I19 The defective metabolism of polysialic acid (polysia) may represent an effective therapeutic target in hd pre-clinical models
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…BackgroundEvidence indicates that defective metabolism of sialic acid-containing glycosphingolipids (gangliosides) play role in the pathogenesis of…”
Get full text
Journal Article -
16
I16 Stimulation of SPHK1 with selective activator K6PC-5 is beneficial in the transgenic R6/2 mouse model of huntington disease
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2018)“…BackgroundHuntington’s disease (HD) is the most common neurodegenerative disorder with no effective cure currently available. Although several agents have been…”
Get full text
Journal Article -
17
I15 Inhibition of S1P degradation is beneficial in the transgenic R6/2 mouse model of huntington disease
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2018)“…BackgroundHuntington’s disease (HD) is the most common neurodegenerative disorder with no effective cure currently available. Over the past few years our…”
Get full text
Journal Article -
18
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease
Published in Molecular therapy (04-01-2023)“…Huntington’s disease (HD) is a fatal neurodegenerative disorder with no effective cure currently available. Over the past few years our research has shown that…”
Get full text
Journal Article -
19
I10 A genome-wide screening in pluripotent cells identifies MTF1 as a novel suppressor of mutant huntingtin toxicity
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…BackgroundHuntington’s disease (HD) is an inherited and incurable neurodegenerative disorder caused by CAG repeat expansions in the huntingtin (HTT) gene. The…”
Get full text
Journal Article -
20
Blood–Brain Barrier Integrity Is Perturbed in a IMecp2/I-Null Mouse Model of Rett Syndrome
Published in Biomolecules (Basel, Switzerland) (01-03-2023)“…Rett syndrome (RTT, online MIM 312750) is a devastating neurodevelopmental disorder characterized by motor and cognitive disabilities. It is mainly caused by…”
Get full text
Journal Article